Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: A prospective 5-year survival study

Gynecologic Oncology

Volumn 53, Issue 1, 1994, Pages 64-69

  Friberg, Lars Gösta ^a   Norén, Håkan ^a   Delle, Ulla ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0028267416     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1994.1089     Document Type: Article

References (23)

1. Johnston, D. A., White, R. A., and Barlogie, B. Automatic processing and interpretation of DNA distributions: Comparison of several techniques, Comput. Biomed. Res. 11, 393-404 (1978).
2. Barlogie, B., Göhde, W., Johnston, D. A., Smallwood, L., Schumann, J., Drewinko, B., and Freireich, E. J. Determination of pioidy and proliferative characteristics of human solid tumors by pulse cytophotometry, Cancer Res. 38, 3333-3339 (1978).
3. Lindahl, B., and Gullberg, B. Flow cytometrical DNA-and clinical parameters in the prediction of prognosis in stage I-II endometrial carcinoma, Anticancer Res. 11(1), 397-401 (1991).
4. Kysela, B., Siracky, J., Redecha, M., and Bardos, A. Flow cytometry (FCM) analysis of endometrial hyperplasia and carcinoma, Neoplasma 37, 489-495 (1990).
5. Quillamor, R. M., Furlong, J. W., Hoschner, J. A., and Wynn, R. M. Relative prognostic significance of DNA flow cytometry and histologic grading in endometrial carcinoma, Gynecol. Obstet. Invest. 26(4), 327-332 (1988).
6. Friedlander, M. L., Hedley, D. W., and Taylor, I. W. Clinical and biological significance of aneuploidy in human tumors, J. Clin. Pathol. 37, 961-974 (1984).
7. Kühn, W., Kaufmann, M., Feichter, G. E., Rummel, H. H., Abel, U., Heep, J., and Minckwitz, G. v. Prognostische bedeutung zell-kinetischer parameter beim endometriumkarzinom, Geburtsh. Frauenheilk. 49, 789-792 (1989).
8. Britton, L. C., Wilson, T. O., Gaffey, T. A., Lieber, M. M., Wieand, H. S., and Podratz, K. C. Flow cytometric DNA analysis of stage I endometrial carcinoma, Gynecol. Oncol. 34, 317-322 (1989).
9. Iversen, O. E., Utaaker, E., and Skaarland, E. DNA pioidy and steroid receptors as predictors of disease course in patients with endometrial carcinoma, Acta Obstet. Gynecol. Scand. 67, 531-537 (1991).
10. Seckinger, D., Sugarbaker, E., and Frankfurt, O. DNA content in human cancer. Application in pathology and clinical medicine, Arch. Pathol. Lab. Med. 113(6), 619-626 (1989).
11. Wieand, H. S., and Podratz, K. C. Flow cytometric DNA analysis of stage I endometrial carcinoma, Gynecol. Oncol. 34, 317-322 (1992).
12. Askensten, U., Moberg, B., and Auer, G. Methodological aspects on cytochemical DNA assessment of adenocarcinoma of the endometrium by means of image and flow cytometry using conventionally formalin-fixed and paraffin-embedded specimens, Arch. Geschwulstforsch. 60(3), 209-216 (1990).
13. Takahashi, Y. DNA pioidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues, Nippon Sanka Fujinka Gakkai Zasshi. 42(10), 1339-1344 (1990).
14. Strang, P., Stendahl, U., Tribukait, B., Wagenius, G., and Boman, K. Age, menopausal status and DNA content in endometrial adenocarcinoma, Anticancer Res. 9, 1079-1082 (1989).
15. Britton, L. C., Wilson, T. O., Gaffey, T. A., Cha, S. S., Wieand, H. S., and Podratz, K. C. DNA pioidy in endometrial carcinoma: Major objective prognostic factor, Mayo Clin. Proc. 65, 643-650 (1990).
16. Iversen, O. E. Prognostic value of flow cytometric DNA index in human ovarian carcinoma, Cancer 61, 971-975 (1988).
17. Kallioniemi, O.-P., Punnonen, R., Mattila, J., Lehtinen, M., and Koivula, T. Prognostic significance of DNA index, multiploidy, and S-phase fraction in ovarian cancer, Cancer 61, 334-339 (1988).
18. Geisinger, K. R., Homesley, H. D., Morgan, T. M., Kute, T. E., and Marshall, R. B. Endometrial adenocarcinoma. A multiparameter clinicopathologic analysis including the DNA profile and the sex steroid hormone receptors, Cancer 58, 1518-1525 (1986).
19. Sorbe, B., Risberg, B., and Frankendal, B. DNA pioidy, morphometry, and nuclear grade as prognostic factors in endometrial carcinoma, Gynecol. Oncol. 38, 22-27 (1990).
20. Kenter, G. G., Cornelisse, C. J., Aartsen, E. J., Mooy, W., Hermans, J., Heintz, A. P. M., and Fleuren, G. J. DNA pioidy levels as prognostic factor in low stage carcinoma of the uterine cervix, Gynecol. Oncol. 39, 181-185 (1990).
21. Rosenberg, P., Wingren, S., Simonsen, E., Stâl, O., Risberg, B., and Nordenskjöld, B. Flow cytometric measurements of DNA index and S-phase on paraffin-embedded early stage endometrial cancer: An important prognostic indicator, Gynecol. Oncol. 35, 50-54 (1989).
22. Thornton, J. G., Quirke, P., and Wells, M. Flow cytometry of normal, hyperplastic, and malignant human endometrium. A study of pioidy and proliferative indices including comparison with in vitro S-phase labelling, Am. J. Obstet. Gynecol. 161, 487-492 (1989).
23. Wagenius, V., Strang, P., Bergström, R., Stendahl, U., and Tribukait, B. Prognostic indices in endometrial adenocarcinoma stages I and II-A study based on clinical, histopathological and flow cytometric variables, Anticancer Res. 11, 2137-2142 (1991).